Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,505,082,911
-$54,454,489 QoQ
Shares Held
2,777,777
+5.6% QoQ
Ownership
6.48%
of shares outstanding
% of Portfolio
13.52%
of 13F equity value
Holder Rank
#2
of 870 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Mar 31, 2026CallValue
$225,332,400
CallShares
380,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Avoro Capital Advisors LLC holds $1,505,082,911 across 1 Drug Manufacturers - Specialty & Generic name. UTHR ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
2,777,777 | $1,505,082,911 |
All Filings in UTHR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,505,082,911 | 2,777,777 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,559,537,400 | 2,630,000 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $225,332,400 | 380,000 | Call | Sole | 2026-05-15 | |
| 2025-09-30 | $847,735,684 | 2,022,222 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $4,440,000 | 200,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $681,019,500 | 2,370,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $824,622,250 | 2,675,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $973,944,252 | 2,760,300 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,024,482,514 | 2,858,888 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $910,698,772 | 2,858,888 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $656,743,751 | 2,858,888 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $628,640,882 | 2,858,888 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $644,294,175 | 2,852,500 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $642,382,279 | 2,909,999 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $642,765,200 | 2,870,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $796,727,850 | 2,865,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $612,750,570 | 2,926,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $699,850,800 | 2,970,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $543,612,300 | 3,030,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $655,802,800 | 3,035,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $553,740,000 | 3,000,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $538,230,000 | 3,000,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $501,810,000 | 3,000,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $432,601,500 | 2,850,000 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||